In short. The oral classes used in hair loss, who they suit, the monitoring they require, and the side effects that must be discussed honestly first.
Key points
- What is this medicine meant to change, how long before we judge it, what monitoring does it need, what should I do if a side effect appears, how long do I expect to take it, and what happens if I stop?
- A clinician who cannot answer these plainly is moving too fast.
Oral treatment is considered when hair loss is extensive, when topical treatment has not done enough, or when the underlying mechanism is hormonal or immune-mediated rather than local to the scalp. Oral agents are more powerful, and they also carry more risk. Every one of them requires a proper conversation about side effects and monitoring before the first dose.
5-alpha reductase inhibitors
This class blocks the enzyme that converts testosterone into the androgen chiefly responsible for follicle miniaturisation. It is used in men with pattern hair loss and is generally the more effective oral option for that group. Because the same enzyme pathway is involved in prostate tissue, the class is well studied. Recognised side effects include reduced libido, erectile and ejaculatory difficulty, and mood change; these affect a minority of users and usually resolve on stopping, although a small number of men report persistence. Many clinicians check baseline liver function and review at three to six months.
Anti-androgen agents
In women whose hair loss is driven by androgens, anti-androgen agents including spironolactone and cyproterone acetate are used, often alongside a topical agent. Spironolactone requires monitoring of blood pressure, potassium and kidney function, and both agents are contraindicated in pregnancy and require reliable contraception in women of childbearing age. They are used off-label for hair loss in many settings, which is a discussion worth having explicitly.
Vasodilator and immune-directed orals
Low-dose oral vasodilator therapy is used in some patients who cannot tolerate or adequately apply topical treatment; it requires baseline blood pressure and cardiac assessment and monitoring for fluid retention, and it is not suitable for everyone. For extensive immune-mediated hair loss, systemic corticosteroids are used in short courses to interrupt active disease, immunosuppressants such as methotrexate are used for maintenance, and Janus kinase inhibitors have changed what is achievable in severe disease at the cost of monitoring for infection and changes in blood counts. Relapse after stopping is common.
The questions worth asking before starting
What is this medicine meant to change, how long before we judge it, what monitoring does it need, what should I do if a side effect appears, how long do I expect to take it, and what happens if I stop? A clinician who cannot answer these plainly is moving too fast.
Seek urgent care if
- You develop breast lumps, nipple discharge, or breast tenderness on a hormonal medicine.
- You have severe abdominal pain, jaundice, dark urine or persistent nausea on an oral agent.
- You experience mood change, low mood, or thoughts of self-harm — stop and seek help promptly.
Frequently asked questions
What side effects should be discussed before starting an oral agent?
The class matters. The 5-alpha reductase inhibitor class can cause reduced libido, erectile and ejaculatory difficulty and mood change, usually resolving on stopping. Anti-androgen agents require monitoring of blood pressure, potassium and kidney function and are contraindicated in pregnancy.
How often is monitoring needed on oral treatment?
It depends on the agent. Many clinicians check baseline liver function and review at three to six months on a 5-alpha reductase inhibitor; anti-androgen agents need blood pressure, potassium and kidney monitoring; oral vasodilator therapy needs baseline blood pressure and cardiac assessment.
Is oral treatment used off-label for hair loss?
In some cases, yes. Anti-androgen agents are used off-label for hair loss in many settings, which is a discussion worth having explicitly, and relapse after stopping immune-directed oral treatment is common.
Risks & Limitations
- Most hair loss is progressive and managed rather than reversed; treatment holds the line more often than it restores it.
- Treatment takes 6–12 months before a response can be judged fairly, and must usually be continued indefinitely to keep the result.
- Stopping treatment commonly means losing the hair that was regained, usually within months.
- Some oral agents cause sexual, mood and metabolic side effects, and several require blood monitoring, blood-pressure monitoring, or pregnancy prevention.
- Hair transplantation moves existing hair; it does not create new hair and does not stop the underlying process.
- Scarring alopecia destroys the follicle permanently, so hair lost before treatment begins cannot be recovered.
- No treatment works for everyone, and response cannot be predicted with certainty.
When to Seek Care
- Sudden patchy hair loss, especially with scalp redness, scaling, itching or pain.
- Hair loss with fever, joint pain, mouth ulcers, or a rash elsewhere on the body.
- Scarring changes: an area of scalp that has become smooth, shiny or pale, with loss of the follicular openings.
- Eyebrow or eyelash loss, which suggests a more extensive or systemic process.
- Hair loss with fatigue, palpitations, weight change, or heavy or irregular periods — a systemic cause needs excluding.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance on hair and scalp disorders
- Chinese Medical Association, Dermatology Branch — clinical guidance
- Cochrane Library — systematic reviews in dermatology
- World Health Organization (WHO) — general health and nutrition resources
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.